Docs
🇬🇧
en
Mint Work
Sign in
Get Started
By
Further analysis of PREVAIL: enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer | NobleID
v1
Further analysis of PREVAIL: enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.
Aragon-Ching JB
AJ
Aragon-Ching JB
NobleID
NI5P60W15R08S88
Type:
Journal Article
Claim Your Authorship
Cite
Sign in to see the full record
Creating an account is free.
Sign in
Create an account
For data access, contact
info@nobleid.org
.